Swiss Cell & Gene Summit

​Join the inaugural Swiss Cell & Gene Summit, an exclusive new forum designed to connect CGT developers, clinical innovators, investors, and manufacturing experts around the most relevant strategic topics shaping the future of cell and gene therapy.

​The summit provides a platform for thought leadership, knowledge exchange, and the development of new collaborations across the global CGT community.

​Inaugural Edition | October 13, 2026

​Switzerland and China: Partnering to Shape the Future of Cell and Gene Therapy

​Switzerland’s position as the world’s leading innovation hub, combined with China’s growing momentum in shaping the global life sciences industry, creates a powerful foundation for advancing cell and gene therapies. In particular, China’s growing experience with investigator initiated trials (IITs) offers a new path to generate early human proof-of-concept data enabling more targeted development and investment decisions.

​Together, these strengths bring the scientific excellence, clinical ambition, manufacturing know how, and market dynamic needed to accelerate the development of more effective therapies and improve outcomes for patients.

​This event will look into how developers and investors can benefit from the best of both worlds.

​Why attend? Gain a practical view of how Swiss and Chinese partners may support CGT development, understand the perspectives of key stakeholders, and identify partnership routes to move from opportunity to execution.